Ensitrelvir Fumaric Acid in Patients with COVID-19 Retrospective Chart Review - Toyohira Park Internal Medicine Clinic
Not Applicable
- Conditions
- COVID-19
- Registration Number
- JPRN-UMIN000051461
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
All 47 patients enrolled in the study were mildly ill, and 9 patients had risk factors for severe disease. All patients, regardless of risk factors for severe disease, showed rapid improvement of fever and clinical symptoms, and no patient developed severe disease. The only side effects were mild diarrhea and soft stool.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 47
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet any of the following criteria are excluded from the study. 1) Patients who were treated off-label 2) Patients who refuse to participate in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method